• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Leading Democratic Presidential Candidates United in Targeting Pharma


October 08, 2015.

Writing in The Hill this week, Peter Sullivan looks at the two-pronged attack on pharma from the leading Democratic candidates for president, Hillary Clinton and Sen. Bernie Sanders (I-Vt.)   Both Clinton and Sanders, notes Sullivan, support allowing Medicare to negotiate down drug prices and permitting imports of cheaper drugs from Canada. In addition, Clinton wants to force drug companies to direct a portion of revenue into research. She is also taking on the insurance companies, urging expanded government authority to block large premium increases and strong enforcement of anti-trust laws.   For his part, Sanders is calling for a national, government-run health insurance system "that would overturn insurance companies’ entire business model", writes Sullivan. Not stopping there, Sanders has also called the pharma industry “a health hazard for the American people.”   For The Hill's take on pharma "under fire", click here.

Recent Videos
Related Content